当前位置: 首页 > 新闻资讯 > 产品文献 > "酶免"产品文献：Biejiajian Pill Promotes the Infiltration of CD8+ T Cells in Hepatocellular Carcinoma by Regulating the Expression of CCL5

"酶免"产品文献：Biejiajian Pill Promotes the Infiltration of CD8+ T Cells in Hepatocellular Carcinoma by Regulating the Expression of CCL5

酶免官方商城 / 2023-02-10

文献标题

Biejiajian Pill Promotes the Infiltration of CD8+ T Cells in Hepatocellular Carcinoma by Regulating the Expression of CCL5

文献作者

XuemeiYang、JialingSun、BinWen、YuWang、MingjiaZhang、WeicongChen、WentingZhao、ChunyuHe、XiaodanZhong、YangLiu、TongLi、HaitaoSun and SongqiHe

发表时间

2021年11月26日

文献影响因子

5.810

使用的酶免试剂盒产品名称

小鼠正常T细胞表达和分泌因子（RANTES/CCL5）ELISA试剂盒
人CC趋化因子配体5（CCL5）ELISA试剂盒

下一篇:"酶免"产品文献：Knockdown of transient receptor potential melastatin 2 reduces renal fibrosis and inflammation by blocking transforming growth factor-β1-activated JNK1 activation in diabetic mice
上一篇:"酶免"产品文献：Purification, Structural Characterization,and Anti-Inflammatory Effects of a Novel PolysaccharideIsolated from Orostachys fimbriata

全部产品分类

浏览历史

"酶免"产品文献：Biejiajian Pill Promotes the Infiltration of CD8+ T Cells in Hepatocellular Carcinoma by Regulating the Expression of CCL5